Job title: Principal Translational Scientist
Michael Pratta currently works as a Principle Research Scientist of Translational Research at the Incyte Research Institute with a focus on immunological and oncological diseases. Michael has extensive experience in the pharmaceutical industry spanning a number of therapeutic areas including inflammation, respiratory, rheumatology, and oncology in early discovery through translational and clinical research. Prior to Incyte, Michael has held roles of increasing responsibility at DuPont Pharma, GlaxoSmithKline, and Centocor/Janssen Pharmaceuticals. Throughout his career, Michael has combined clinical, translational, and basic science to identify personalized medicine approaches to treat immunological diseases. His work has been highlighted in national meetings, publications, and patents for therapeutic interventions and biomarker strategies.
Identifying a Biomarker Signature to Predict Complete Response to Itacitinib & Corticosteroids in Acute Graft Versus Host Disease 12:00 pm
Acute graft versus host disease (aGVHD) is a potentially life threatening disease that develops in patients following hematopoietic stem cell transplantation Important need for biomarkers which can stratify responders and non-responders in clinical trial settings to facilitate more personalized approaches to treatment Broad proteomic analysis of aGVHD patients treated with the combination of itacitinib and…Read more
day: Day One